A motion has been filed with the MDL Panel to consolidate over 20 Depo-Provera lawsuits in the U.S. District Court for the Northern District of California. The motion cites the high number of cases already filed in California, including 18 out of 22 referenced lawsuits, and the state’s unique innovator liability laws that allow plaintiffs to sue the brand-name manufacturer, Pfizer, even if they used generic versions of the drug.
California is seen as a key jurisdiction for this litigation due to its large population of Depo-Provera users and a recent study linking the drug to a 550% increased risk of intracranial meningiomas. The motion anticipates thousands of additional cases, making the Northern District a strategic venue for streamlining proceedings and addressing the growing number of claims.
